Methyl 4-(bromomethyl)-3-fluorobenzoate, 95.0%, 100mg

1-Bromo-pyrene, 99.00%, 1g

1-((3aR,6S,7aS)-8,8-Dimethyl-2,2-dioxidohexahydro-1H-3a,6-methanobenzo[c]isothiazol-1-yl)propan-1-one, 95.0%, 1g

1-Vinyl-2-pyrrolidone (stabilized with N,N'-Di-sec-butyl-p-phenylenediamine)>99.0%(GC)25mL

rel-(3R,4S)-tert-Butyl 3-allyl-4-hydroxypyrrolidine-1-carboxylate, 98%, 100mg

3-Ethylisoxazol-5-amine, 95.0%, 10g

2,8-Bis(diphenylphosphoryl)dibenzo[b,d]furan>96.0%(HPLC)1g

8-Bromo-5-chloro-1,2,4-triazolo[4,3-a]pyridine, 5g

4-Aminopyrrolidin-2-one hydrochloride, 95.0%, 1g

3-[(1-ethyl-1H-benzimidazol-2-yl)thio]propanoic acid, 95.0%, 1g

Sodium 3-(allyloxy)-2-hydroxypropane-1-sulfonate (40 wt. % in H2O), 95.0%, 25g

N,N'-(1H-Pyrazole-3,5-diyl)diacetamide, 97.0%, 1g

3-(4-Heptylbenzoyl)-4-methylpyridine, 97.0%, 1g